Skip to main content

Advertisement

SpringerLink
Log in

Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management

  • Educational Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Pheochromocytomas and paragangliomas (PPGLs) generally grouped together are rare catecholamine-secreting endocrine tumors. Symptoms of catecholamine excess are non-specific and therefore a high index of suspicion in children with sustained hypertension, family history of endocrine tumors, or features of syndromes associated with PPGLs leads to a timely diagnosis and treatment. Free metanephrines in the plasma or 24-h urine are the preferred tests to establish catecholamine excess. Considerations for false-positive conditions improve diagnostic yield and accuracy. Functional imaging, targeting either specific cell membrane transporters or vesicular catecholamine transport systems, is indicated for incidental lesions suspicious for PPGLs with inconclusive biochemical testing, assessment of regional extension or multifocality, and exclusion of metastases. Surgery is the mainstay of treatment for PPGLs. Preoperatively, sequential use of alpha adrenergic receptor blockade and volume expansion followed by beta blockade is mandatory to reduce intraoperative intravascular instability and blood pressure fluctuation due to tumor manipulation. Since genetic mutations have been reported in tumor susceptibility genes in nearly 50% of patients with PPGLs, genetic counselling and testing should be considered in all patients with a confirmed tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, AM MN, Tischler AS, International Symposium on Pheochromocytoma (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3:92–102

    Article  PubMed  Google Scholar 

  2. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr, Endocrine Society (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915–1942

    Article  CAS  PubMed  Google Scholar 

  3. Turchini J, Cheung VKY, Tischler AS, De Krijger RR, Gill AJ (2018) Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology 72:97–105

    Article  PubMed  Google Scholar 

  4. Kirmani S, Young WF (1993) In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, Amemiya A (eds) Hereditary paraganglioma-pheochromocytoma syndromes. GeneReviews((R)), Seattle

    Google Scholar 

  5. Lefebvre M, Foulkes WD (2014) Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol 21:e8–e17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Barontini M, Levin G, Sanso G (2006) Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci 1073:30–37

    Article  PubMed  Google Scholar 

  7. King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP, McCormack S, Eisenhofer G, Milosevic D, Kebebew E, Stratakis CA, Pacak K (2011) Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29:4137–4142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K (2009) Update on pediatric pheochromocytoma. Pediatr Nephrol 24:943–950

    Article  PubMed  Google Scholar 

  9. Tischler AS (2008) Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med 132:1272–1284

    Article  PubMed  Google Scholar 

  10. Bholah R, Bunchman TE (2017) Review of pediatric pheochromocytoma and paraganglioma. Front Pediatr 5:155

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lenders JWM, Eisenhofer G (2017) Update on modern management of pheochromocytoma and paraganglioma. Endocrinol Metab (Seoul) 32:152–161

    Article  CAS  Google Scholar 

  12. Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, Sidhu SB (2008) Pheochromocytoma: current approaches and future directions. Oncologist 13:779–793

    Article  PubMed  Google Scholar 

  13. Dahia PL (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14:108–119

    Article  CAS  PubMed  Google Scholar 

  14. Kavinga Gunawardane PT, Grossman A (2017) The clinical genetics of phaeochromocytoma and paraganglioma. Arch Endocrinol Metab 61:490–500

    Article  CAS  PubMed  Google Scholar 

  15. Fishbein L, Orlowski R, Cohen D (2013) Pheochromocytoma/paraganglioma: review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma. J Clin Hypertens (Greenwich) 15:428–434

    Article  CAS  Google Scholar 

  16. Stratakis CA, Carney JA (2009) The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med 266:43–52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Boikos SA, Xekouki P, Fumagalli E, Faucz FR, Raygada M, Szarek E, Ball E, Kim SY, Miettinen M, Helman LJ, Carney JA, Pacak K, Stratakis CA (2016) Carney triad can be (rarely) associated with germline succinate dehydrogenase defects. Eur J Hum Genet 24:569–573

    Article  CAS  PubMed  Google Scholar 

  18. Sarathi V (2017) Characteristics of pediatric Pheochromocytoma/paraganglioma. Indian J Endocrinol Metab 21:470–474

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, Walz MK, Peczkowska M, Weryha G, Dall'igna P, Cecchetto G, Bisogno G, Moeller LC, Bockenhauer D, Patocs A, Racz K, Zabolotnyi D, Yaremchuk S, Dzivite-Krisane I, Castinetti F, Taieb D, Malinoc A, von Dobschuetz E, Roessler J, Schmid KW, Opocher G, Eng C, Neumann HP (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21:17–25

    Article  PubMed  Google Scholar 

  20. Mishra A, Mehrotra PK, Agarwal G, Agarwal A, Mishra SK (2014) Pediatric and adolescent pheochromocytoma: clinical presentation and outcome of surgery. Indian Pediatr 51:299–302

    Article  PubMed  Google Scholar 

  21. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C (2010) A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95:2023–2037

    Article  CAS  PubMed  Google Scholar 

  22. Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366:665–675

    Article  PubMed  Google Scholar 

  23. Ceruti M, Petramala L, Cotesta D, Cerci S, Serra V, Caliumi C, Iorio M, De Toma G, Ciardi A, Vitolo D, Letizia C (2006) Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens (Greenwich) 8:642–648

    Article  Google Scholar 

  24. Welander J, Soderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253–R276

    Article  CAS  PubMed  Google Scholar 

  25. Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31:41–51

    Article  CAS  PubMed  Google Scholar 

  26. Torres AD, Rai AN, Hardiek ML (2000) Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics 105:E34

    Article  CAS  PubMed  Google Scholar 

  27. Remer T, Neubert A, Maser-Gluth C (2002) Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 75:561–569

    Article  CAS  PubMed  Google Scholar 

  28. Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr (2007) The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol 66:703–708

    Article  CAS  Google Scholar 

  29. Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G (2002) Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab 87:1955–1960

    Article  CAS  PubMed  Google Scholar 

  30. Mazzaglia PJ (2012) Hereditary pheochromocytoma and paraganglioma. J Surg Oncol 106:580–585

    Article  CAS  PubMed  Google Scholar 

  31. Taieb D, Pacak K (2018) Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma. Cell Tissue Res 372:393–401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Neary NM, King KS, Pacak K (2011) Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine. N Engl J Med 364:2268–2270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hannah-Shmouni F, Pacak K, Stratakis CA (2017) Metanephrines for evaluating palpitations and flushing. JAMA 318:385–386

    Article  PubMed  PubMed Central  Google Scholar 

  34. Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M (2009) Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am J Med 122:85–95

    Article  PubMed  Google Scholar 

  35. Shulkin BL, Shapiro B (1998) Current concepts on the diagnostic use of MIBG in children. J Nucl Med 39:679–688

    CAS  PubMed  Google Scholar 

  36. Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K (2012) Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst 104:700–708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kocyigit Deveci E, Ocak M, Bozkurt MF, Turker S, Kabasakal L, Ugur O (2013) The diagnostic efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in comparison with 111In-pentetrotide in the detection of neuroendocrine tumours. Mol Imaging Radionucl Ther 22:76–84

    Article  PubMed  PubMed Central  Google Scholar 

  38. Gruber LM, Erickson D, Babovic-Vuksanovic D, Thompson GB, Young WF Jr, Bancos I (2017) Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol 86:141–149

    Article  CAS  Google Scholar 

  39. Tufton N, Sahdev A, Akker SA (2017) Radiological surveillance screening in asymptomatic succinate dehydrogenase mutation carriers. J Endocr Soc 1:897–907

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Schuttler J, Westhofen P, Kania U, Ihmsen H, Kammerecker S, Hirner A (1995) Quantitative assessment of catecholamine secretion as a rational principle of anesthesia management in pheochromocytoma surgery. Anasthesiol Intensivmed Notfallmed Schmerzther 30:341–349

    Article  CAS  PubMed  Google Scholar 

  41. Apgar V, Papper EM (1951) Pheochromocytoma. Anesthetic management during surgical treatment. AMA Arch Surg 62:634–648

    Article  CAS  PubMed  Google Scholar 

  42. Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G (2001) Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 86:1480–1486

    CAS  PubMed  Google Scholar 

  43. Beltsevich DG, Kuznetsov NS, Kazaryan AM, Lysenko MA (2004) Pheochromocytoma surgery: epidemiologic peculiarities in children. World J Surg 28:592–596

    Article  PubMed  Google Scholar 

  44. Agrawal R, Mishra SK, Bhatia E, Mishra A, Chand G, Agarwal G, Agarwal A, Verma AK (2014) Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg 38:716–723

    Article  PubMed  Google Scholar 

  45. Weingarten TN, Cata JP, O'Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E, Sprung J (2010) Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76(508):e506–e511

    Google Scholar 

  46. Prys-Roberts C, Farndon JR (2002) Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 26:1037–1042

    Article  PubMed  Google Scholar 

  47. Kocak S, Aydintug S, Canakci N (2002) Alpha blockade in preoperative preparation of patients with pheochromocytomas. Int Surg 87:191–194

    PubMed  Google Scholar 

  48. Hull CJ (1986) Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth 58:1453–1468

    Article  CAS  PubMed  Google Scholar 

  49. Sibal L, Jovanovic A, Agarwal SC, Peaston RT, James RA, Lennard TW, Bliss R, Batchelor A, Perros P (2006) Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clin Endocrinol 65:186–190

    Article  CAS  Google Scholar 

  50. Bravo EL (2002) Pheochromocytoma: an approach to antihypertensive management. Ann N Y Acad Sci 970:1–10

    Article  CAS  PubMed  Google Scholar 

  51. Lund-Johansen P (1984) Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. Drugs 28(Suppl 2):35–50

    Article  PubMed  Google Scholar 

  52. Briggs RS, Birtwell AJ, Pohl JE (1978) Hypertensive response to labetalol in phaeochromocytoma. Lancet 1:1045–1046

    Article  CAS  PubMed  Google Scholar 

  53. Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, Vescovo G, Zuin M, Chondrogiannis S, Ravenni R, Opocher G, Colletti PM, Rubello D (2014) Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45:469–478

    Article  CAS  PubMed  Google Scholar 

  54. Romero M, Kapur G, Baracco R, Valentini RP, Mattoo TK, Jain A (2015) Treatment of hypertension in children with catecholamine-secreting tumors: a systematic approach. J Clin Hypertens (Greenwich) 17:720–725

    Article  CAS  Google Scholar 

  55. Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, Vallet B, Proye CA (2005) The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia 60:439–444

    Article  CAS  PubMed  Google Scholar 

  56. Ludwig AD, Feig DI, Brandt ML, Hicks MJ, Fitch ME, Cass DL (2007) Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg 194:792–796 discussion 796-797

    Article  CAS  PubMed  Google Scholar 

  57. Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr (1997) Metyrosine and pheochromocytoma. Arch Intern Med 157:901–906

    Article  CAS  PubMed  Google Scholar 

  58. Petrak O, Haluzikova D, Kavalkova P, Strauch B, Rosa J, Holaj R, Brabcova Vrankova A, Michalsky D, Haluzik M, Zelinka T, Widimsky J Jr (2013) Changes in energy metabolism in pheochromocytoma. J Clin Endocrinol Metab 98:1651–1658

    Article  CAS  PubMed  Google Scholar 

  59. Hack HA (2000) The perioperative management of children with phaeochromocytoma. Paediatr Anaesth 10:463–476

    Article  CAS  PubMed  Google Scholar 

  60. Kalra Y, Agarwal HS, Smith AH (2013) Perioperative management of pheochromocytoma and catecholamine-induced dilated cardiomyopathy in a pediatric patient. Pediatr Cardiol 34:2013–2016

    Article  PubMed  Google Scholar 

  61. Bryskin R, Weldon BC (2010) Dexmedetomidine and magnesium sulfate in the perioperative management of a child undergoing laparoscopic resection of bilateral pheochromocytomas. J Clin Anesth 22:126–129

    Article  CAS  PubMed  Google Scholar 

  62. Minami T, Adachi T, Fukuda K (2002) An effective use of magnesium sulfate for intraoperative management of laparoscopic adrenalectomy for pheochromocytoma in a pediatric patient. Anesth Analg 95:1243–1244

    Article  PubMed  Google Scholar 

  63. Castilho LN, Castillo OA, Denes FT, Mitre AI, Arap S (2002) Laparoscopic adrenal surgery in children. J Urol 168:221–224

    Article  PubMed  Google Scholar 

  64. Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB (2004) Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198:525–534 discussion 534-525

    Article  PubMed  Google Scholar 

  65. Mannelli M (2006) Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci 1073:405–416

    Article  PubMed  Google Scholar 

  66. van Hulsteijn LT, Niemeijer ND, Dekkers OM, Corssmit EP (2014) (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol 80:487–501

    Article  CAS  Google Scholar 

  67. Asai S, Katabami T, Tsuiki M, Tanaka Y, Naruse M (2017) Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant pheochromocytomas/paragangliomas. Horm Cancer 8:108–118

    Article  CAS  PubMed  Google Scholar 

  68. Vogel J, Atanacio AS, Prodanov T, Turkbey BI, Adams K, Martucci V, Camphausen K, Fojo AT, Pacak K, Kaushal A (2014) External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma. Front Oncol 4:166

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Nephrology and Hypertension, Children’s Hospital of Michigan, Wayne State University School of Medicine, 5th Floor, Carl’s Building, 3901 Beaubien Blvd, Detroit, MI, 48201, USA

    Amrish Jain, Rossana Baracco & Gaurav Kapur

Authors
  1. Amrish Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rossana Baracco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gaurav Kapur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaurav Kapur.

Ethics declarations

Conflict of interest

The authors certify that they have no affiliation with organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this manuscript.

Additional information

Answers

1. d; 2. d; 3. e; 4. b; 5. d

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, A., Baracco, R. & Kapur, G. Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management. Pediatr Nephrol 35, 581–594 (2020). https://doi.org/10.1007/s00467-018-4181-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-018-4181-2

Keywords

Search

Navigation